Officials said they will submit the new trial results to the FDA to bolster its case that lecanemab should be approved as an Alzheimer’s treatment.
Author: Ken Alltucker, USA TODAY
Searching for a nursing home? Biden administration takes ‘unprecedented step’ to release ownership data
The nursing home data is part of the Biden administration’s effort to shine a light on an industry that receives substantial federal funding.
HIV groups struggle to get insurance coverage for expensive prevention drugs, lab tests
HIV activists say people who are eligible for free HIV prevention care often don’t get full coverage even though federal law says they should.
Patients seek relief from spiraling drug prices. Will the Inflation Reduction Act deliver?
Cancer and multiple sclerosis patients insured by Medicare are among those awaiting lower drug prices from the Inflation Reduction Act.
How the Inflation Reduction Act would save Medicare drug costs
Inflation Reduction Act would grant Medicare the authority to negotiate drug prices and cap out-of-pocket costs at $2,000 a year.
‘Almost useless’: Patients, advocates critical of federal pace to unlock hospital prices
Consumers are left in the dark about hospital prices before getting care. Now they want Medicare to enforce a new federal price transparency law .
Even America’s fittest cities have the blues; How exercise can improve mental health
Arlington, Virginia, is still tops in an annual ranking of the nation’s fittest cities, but mental health was a growing concern for all cities.
Hospitals must say how much they charge for hundreds of procedures. Here’s why many don’t.
More than half of U.S. hospitals have not shared pricing information as required by a new federal law. Consumer advocates urge federal enforcement.
Juul’s appeal allows it to sell vaping devices, pods as federal court weighs FDA ban.
In appealing the ban, Juul says the FDA acted on political pressure from Congress blaming it for the youth vaping epidemic.
Report: Federal ban on popular Juul products forthcoming amid youth vaping concerns
The FDA has reviewed applications from Juul and hundreds of other vaping companies amid calls to crack down on youth vaping.